UPDATE PREMIA and AmoyDx Announce Strategic Partnership to Establish Asia Cancer Clinical Genomic Network

UPDATE – PREMIA and AmoyDx Announce Strategic Partnership to Establish Asia Cancer Clinical Genomic Network

21:09 EDT 24 Jun 2019 | Biotech 365

HONG KONG, June 24, 2019 (GLOBE NEWSWIRE) — Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, has entered into a strategic partnership agreement with Amoy Diagnostics Co., Ltd. (AmoyDx) and PREMIA Holdings (HK) Ltd. Under the … Continue reading →

More From BioPortfolio on "UPDATE – PREMIA and AmoyDx Announce Strategic Partnership to Establish Asia Cancer Clinical Genomic Network"